Literature DB >> 933293

Studies of introital colonization in women with recurrent urinary infection. VI. Analysis of segmented leukocytes on the vaginal vestibule in relation to enterobacterial colonization.

T A Stamey, G Mihara.   

Abstract

Segmented leukocytes on the vaginal vestibule were quantitated in 93 specimens from 27 women with recurrent bacteriuria (1.03 times 10(5) plus or minus 4.9 times 10(5) cells per ml.) and compared to 251 specimens from 26 control women who had never had bacteriuria (8.0 times 10(4) plus or minus 1.7 times 10(5)). There was no significant difference (p more than 0.6). Leukocyte counts accompanying colonization with more than 100 Enterobacteriaceae per ml. (6.4 times 10(4) plus or minus 1.0 times 10(5) cells per ml). were no different from those unaccompanied by Enterobacteriaceae (8.7 times 10(4) plus or minus 3.3 times 10(5) cells per ml., p more than 0.9). No distinctive pattern was observed in excretion of vaginal leukocytes during the menstrual cycles of 21 premenopausal, control volunteers.

Entities:  

Mesh:

Year:  1976        PMID: 933293     DOI: 10.1016/s0022-5347(17)58682-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

Review 1.  Pathogenic factors in recurrent urinary tract infections and renal scar formation in children.

Authors:  W Mannhardt; O Schofer; H Schulte-Wissermann
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

2.  Host defense within the urinary tract. I. Bacterial adhesion initiates an uroepithelial defense mechanism.

Authors:  W Mannhardt; A Becker; M Putzer; M Bork; F Zepp; J Hacker; H Schulte-Wissermann
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

3.  Comparison of the antibacterial effect of uroepithelial cells from healthy donors and children with asymptomatic bacteriuria.

Authors:  H Schulte-Wissermann; W Mannhardt; J Schwarz; F Zepp; D Bitter-Suermann
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.